Items for Author "Kao, JH"
Return to Browse by Author
Showing 11 items.
|
Collection |
Date |
Title |
Authors |
Bitstream |
| [中山醫學大學研究成果] 其他文獻 |
2021 |
EIGHT-YEAR ENTECAVIR THERAPY CONTINUOUSLY REDUCES LIVER ADVERSE EVENTS IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS |
Su, TH; Hu, TH; Chuang, WL; Su, WW; Lin, CC; Peng, CY; Wang, CC; Hsu, YC; Huang, YW; Tseng, KC; Lin, CL; Yang, SS; Suk, FM; Hsu, SJ; Chen, TM; Bair, MJ; Lin, CK; Hsieh, TY; Wang, HY; Tseng, TC; Kao, JH |
|
| [中山醫學大學研究成果] 其他文獻 |
2020 |
IMPACT OF SOFOSBUVIR-BASED VERSUS NON-SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS ON RENAL FUNCTION IN CHRONIC HEPATITIS C PATIENTS WITH IMPAIRED RENAL FUNCTION- A LARGE COHORT STUDY FROM THE NATIONWIDE REAL-WORLD HCV REGISTRY PROGRAM (TACR) |
Yu, ML; Chen, CY; Yi, C; Cheng, PN; Tseng, KC; Lo, CC; Hung, CH; Lin, CY; Chen, CH; Peng, CY; Bair, MJ; Hsieh, TY; Lee, PL; Yang, CC; Lin, CL; Mo, LR; Su, WW; Tsai, WL; Chang, CC; Lin, CC; Hsu, SJ; Liu, CH; Huang, YH; Hu, CT; Liu, CJ; Kao, JH; Lee, MH; Chien, RN; Dai, CY; Tsai, PC |
|
| [中山醫學大學研究成果] 其他文獻 |
2020 |
Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? |
Hsu, SJ; Yang, SS; Kao, JH |
 |
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment |
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan |
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan |
Liu, CH; Chen, PY; Chen, JJ; Lo, CC; Su, WW; Tseng, KC; Liu, CJ; Huang, CS; Huang, KJ; Yang, SS; Peng, CY; Tsai, MC; Kao, WY; Chang, CY; Shih, YL; Fang, YJ; Chen, CY; Lee, PL; Huang, JJ; Su, PY; Tseng, CW; Hung, CC; Chang, CH; Huang, YJ; Lai, HC; Chang, CC; Lee, FJ; Hsieh, TY; Kao, JH |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment |
Liu, CH; Peng, CY; Kao, WY; Yang, SS; Shih, YL; Lin, CL; Tsai, MK; Lee, CY; Chang, CC; Wu, JH; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Kao, JH |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis |
Liu, CH; Chen, CY; Su, WW; Liu, CJ; Lo, CC; Huang, KJ; Chen, JJ; Tseng, KC; Chang, CY; Peng, CY; Shih, YL; Huang, CS; Kao, WY; Yang, SS; Tsai, MC; Wu, JH; Chen, PY; Su, PY; Hwang, JJ; Fang, YJ; Lee, PL; Tseng, CW; Lee, FJ; Lai, HC; Hsieh, TY; Chang, CC; Chang, CH; Huang, YJ; Kao, JH |
|
| [中山醫學大學研究成果] 期刊論文 |
2020 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment |
Liu, CH; Yang, SS; Peng, CY; Lin, WT; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH |
|
| [中山醫學大學研究成果] 期刊論文 |
2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy |
Chang, WY; Chiu, YC; Chiu, FW; Hsu, YC; Tseng, TC; Cheng, PN; Yang, SS; Liu, CJ; Su, TH; Yang, HC; Liu, CH; Chen, PJ; Chen, DS; Kao, JH |
|
| [中山醫學大學研究成果] 期刊論文 |
2020 |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis |
Liu, CH; Peng, CY; Fang, YJ; Kao, WY; Yang, SS; Lin, CK; Lai, HC; Su, WP; Fang, SU; Chang, CC; Su, TH; Liu, CJ; Chen, PJ; Chen, DS; Kao, JH |
|
|
